Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Susan J. Maygarden"'
Autor:
Christopher G. Wood, James E. Ferguson III, Joel S. Parker, Dominic T. Moore, Jennifer G. Whisenant, Susan J. Maygarden, Eric M. Wallen, William Y. Kim, Mathew I. Milowsky, Kathryn E. Beckermann, Nancy B. Davis, Scott M. Haake, Jose A. Karam, Dante S. Bortone, Benjamin G. Vincent, Thomas Powles, W. Kimryn Rathmell
Publikováno v:
JCI Insight, Vol 5, Iss 22 (2020)
BACKGROUND Surgery remains the frontline therapy for patients with localized clear cell renal cell carcinoma (ccRCC); however, 20%–40% recur. Angiogenesis inhibitors have improved survival in metastatic patients and may result in responses in the n
Externí odkaz:
https://doaj.org/article/514517eaefb4496c854f9e31607be03d
Publikováno v:
American Journal of Clinical Pathology. 158:383-388
Objectives Neoadjuvant chemotherapy (NAC) confers a survival advantage for muscle-invasive bladder cancer and is now recommended for chemotherapy-eligible patients. NAC may result in absent gross tumor, and current cystectomy gross examination protoc
Publikováno v:
American journal of clinical pathology. 158(3)
Neoadjuvant chemotherapy (NAC) confers a survival advantage for muscle-invasive bladder cancer and is now recommended for chemotherapy-eligible patients. NAC may result in absent gross tumor, and current cystectomy gross examination protocols do not
Publikováno v:
American Journal of Surgical Pathology. 43:1510-1517
Many physicians share the perception that the work required to evaluate breast pathology specimens is undervalued by Current Procedural Terminology (CPT) codes. To examine this issue, we compared slide volumes from an equal number of breast and nonbr
Autor:
Jordan Kardos, Ethan Basch, David D. Chism, Ajjai Alva, Tracy L. Rose, Mary W. Dunn, Susan J. Maygarden, Paul A. Godley, Anthony Drier, Young E. Whang, Matthew I. Milowsky, William Y. Kim, Allison M. Deal
Publikováno v:
British Journal of Cancer
Background The majority of urothelial cancers (UC) harbor alterations in retinoblastoma (Rb) pathway genes that can lead to loss of Rb tumour suppressor function. Palbociclib is an oral, selective inhibitor of CDK 4/6 that restores Rb function and pr
Autor:
Dante S. Bortone, Benjamin G. Vincent, Thomas Powles, Eric Wallen, Christopher G. Wood, Nancy B. Davis, William Y. Kim, Susan J. Maygarden, Mathew I. Milowsky, Jennifer G. Whisenant, Kathryn E. Beckermann, W. Kimryn Rathmell, Jose A. Karam, Dominic T. Moore, James E. Ferguson, Joel S. Parker, Scott M. Haake
Publikováno v:
JCI Insight
JCI Insight, Vol 5, Iss 22 (2020)
JCI Insight, Vol 5, Iss 22 (2020)
BACKGROUND Surgery remains the frontline therapy for patients with localized clear cell renal cell carcinoma (ccRCC); however, 20%–40% recur. Angiogenesis inhibitors have improved survival in metastatic patients and may result in responses in the n
Publikováno v:
The American surgeon. 86(3)
Outcome of radioiodine therapy in thyroid cancer patients with recent contrasted computed tomography
Autor:
Trevor Hackman, Deepa Kirk, Thad Benefield, Lawrence T. Kim, Justin D Rodriguez, Susan J. Maygarden, Amir H. Khandani, Karla Pou
Publikováno v:
Nuclear medicine communications. 41(3)
Objective To document the outcome of radioiodine therapy (RIT) in differentiated thyroid cancer (DTC) patients with recent contrasted computed tomography (CCT). Methods Eighteen patients with DTC and recent thyroidectomy who underwent RIT within 90 d
Autor:
Thad Benefield, Daniel S. Reuland, Adam O. Goldstein, Susan J. Maygarden, Alison T. Brenner, Louise M. Henderson, Laura Jones, Maria Patricia Rivera, Paul L. Molina, Mary W. Marsh
Publikováno v:
North Carolina medical journal. 80(1)
BACKGROUND: In response to the National Lung Screening Trial, numerous professional organizations published guidelines recommending annual lung cancer screening with low-dose computed tomography (LDCT) for high-risk patients. Prior studies found that
Publikováno v:
American Journal of Surgical Pathology. 44:567-567